Not-for-profit celebrates past achievements and looks to the future POWELL, Ohio, February 29, 2024 (Newswire.com) - The Siegel Rare [...]
I got an email recently from someone well up the chain of command at a multiple sclerosis (MS) patient advocacy organization. The purpose [...]
Genentech’s Ocrevus Twice-Yearly, 10-Minute Subcutaneous Injection Was Non-Inferior to Intravenous Infusion and Provided Near-Complete [...]
MIDDLETON, WI., July 19, 2023 - An international consortium led by the Americas Committee for Treatment and Research in Multiple [...]
The MS+ community has lost its 'grandfather.' Barry GW Arnason, MD, FAAN. He is generally regarded as one of (if not, the) founder of [...]
Phase III OCARINA II trial met primary and secondary endpoints Ocrevus 10-minute injection has the potential to further improve the [...]
Abstracts for CMSC 2023 Annual Meeting Reflect Latest Multidisciplinary Multiple Sclerosis Research The 37th Annual Meeting of the [...]
CMSC 2023 Annual Meeting Program Offers Cutting-Edge Science and Clinical Skill Updates for MS Care Professionals CMSC (Consortium of [...]
CRANBURY, N.J., April 26, 2023 (GLOBE NEWSWIRE) -- NeurologyLive® and the Consortium of Multiple Sclerosis Centers (CMSC) are pleased [...]
DEI Statement will be Released at the CMSC Annual Meeting, May 31–June 3 in Aurora, CO HACKENSACK, NEW JERSEY, USA, May 26, [...]